Of the two versions of the genome map, one is by for-profit Celera Genomics, the other by a publicly funded group led by the National Institutes of Health. They've chosen the world's two foremost science journals to publish their work, and therein lies controversy. Science magazine gets Celera's map. The journal normally allows unfettered access by researchers to the data behind its articles. But not this time. And that has some researchers worried that business is usurping openness in science. NPR's David Kestenbaum reports
Copyright 2001 NPR